ArticleTherapeutic advances in medical oncology2023

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancer.

Shani Paluch-Shimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.